Amgen nears its highs, but signal strength fades
Amgen +2.7%: the rally tests the highs as signal strength cools
Amgen nears its highs, but signal strength fades
Our view last week
Amgen's stock steadies after last week's slide: this week it adds 0.8% and confirms the double bottom in the 336 area, with a 7% intermediate rebound behind it. The weekly structure stays solid — moving averages aligned, price above the Ichimoku cloud — but buyer dominance keeps fading. Five weeks into the buy signal, the gain sits at 3.12% since entry, and in technical analysis terms the stock is working just under its first resistance.
This week's summary
Amgen shares add 2.7% this week and confirm the double bottom in the 338 area that emerged a week ago, with the rebound now carrying the stock within a whisker of its all-time high. The rally, though, keeps running into the daily upper Bollinger Band, which has turned it back for the second time in a month, and the 7-day high remains only grazed. In technical analysis terms the buy signal is in its sixth week, but signal strength drops to 29 out of 100 just as earnings approach.
IQS Phase
81
in tension / maturity
Signal Strength
29
low · fading
Sizing
MINIMUM
Ranking
#114 / 124
US stocks in progress
Trade P&L %
+5.87%
from signal to today
Rank position
ranks 114th among the 124 Longs already running for US stocks in our ranking, with a signal strength of 29 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
AMGN belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content